Suprathel4 Use During Prolonged Field Care to Promote Healing and Reduce the Need for Grafting of Burn Wounds

What this Trial Is About

This research aims to study the use of Suprathel4, a synthetic wound dressing made from polymers of D-,L-lactate and b5 caprolactone, to help heal burn wounds during prolonged field care situations, especially in large-scale combat operations. The study compares Suprathel4 to standard wound care to see if it can reduce the need for skin grafting, pain, infections, medical staff workload, scarring, and treatment costs. Suprathel4's portability and ease of use by non-medical personnel make it a promising option for early burn coverage. Participants will be randomly assigned to one of two groups: one receiving the Suprathel4 dressing after standard cleaning and debridement of the wound, and the other receiving standard wound care dressings following the same cleaning process. The Suprathel4 dressing will be maintained according to the manufacturer's instructions. The study focuses on partial-thickness burns covering at least 2% of the body surface area but excludes certain body areas like the face and feet. During the study, participants will be monitored for the need for skin grafting over 21 days. Other assessments include wound infection rates, wound closure at 2, 3, and 6 weeks, scar healing evaluated by a scar assessment scale over 3 to 12 months, and patient-reported pain levels from the day of application through weekly follow-ups. The study will track these outcomes to determine how Suprathel4 compares to standard care in promoting burn wound healing and reducing complications.

Suprathel® Use During Prolonged Field Care to Promote Healing and Reduce the Need for Grafting of Burn Wounds